| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
BNTX
BioNTech SE
|
Sep 15, 2026 | BUY |
Strong Buy
+36.2% avg upside
26 analysts
|
$140.00
42.03% Upside
|
+1.9% | · |
|
DE:SRT3
Sartorius
|
Sep 11, 2026 | BUY |
Strong Buy
+8.0% avg upside
19 analysts
|
$280.00
8.46% Upside
|
+13.3% | · |
|
QGEN
Qiagen
|
Sep 10, 2026 | HOLD |
Buy
-2.3% avg upside
24 analysts
|
$45.50
2.94% Upside
|
+4.9% | · |
|
SE:SOBI
Swedish Orphan Biovitrum AB
|
Sep 10, 2026 | BUY |
Strong Buy
+3.1% avg upside
7 analysts
|
$560.00
28.47% Upside
|
-0.5% | · |
|
MRNA
Moderna
|
Sep 10, 2026 | HOLD |
Hold
-48.0% avg upside
38 analysts
|
$100.00
49.71% Downside
|
+45.6% | · |
|
CH:TECN
Tecan Group AG
|
Sep 10, 2026 | BUY |
Buy
+46.4% avg upside
9 analysts
|
$240.00
7.43% Upside
|
+0.0% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.